• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    NewAmsterdam Pharma Company N.V. - Warrant (NQ:NAMSW)

    14.44 -2.07 (-12.54%)
    Streaming Delayed Price Updated: 1:21 PM EDT, Sep 3, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 6,827
    Open 13.05
    Bid (Size) 0.0004 (100)
    Ask (Size) 16.00 (300)
    Prev. Close 16.51
    Today's Range 13.05 - 14.49
    52wk Range 12.69 - 30.45
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From NewAmsterdam Pharma N.V.
    Via GlobeNewswire
    News headline image
    NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in September
    From NewAmsterdam Pharma N.V.
    Via GlobeNewswire

    Performance

    YTD
    -37.5%
    -37.5%
    1 Month
    -9.8%
    -9.8%
    3 Month
    -32.2%
    -32.2%
    6 Month
    -22.4%
    -22.4%
    1 Year
    +3.7%
    +3.7%

    More News

    Read More
    News headline image
    NewAmsterdam Pharma Announces Upcoming Presentations at the European Society of Cardiology (ESC) Congress 2026
    From NewAmsterdam Pharma N.V.
    Via GlobeNewswire
    News headline image
    NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From NewAmsterdam Pharma N.V.
    Via GlobeNewswire
    News headline image
    NewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter Financial Results
    From NewAmsterdam Pharma N.V.
    Via GlobeNewswire
    News headline image
    NewAmsterdam Pharma to Host Investor Day on August 5, 2026
    From NewAmsterdam Pharma N.V.
    Via GlobeNewswire
    News headline image
    NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)
    From NewAmsterdam Pharma N.V.
    Via GlobeNewswire
    News headline image
    NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From NewAmsterdam Pharma N.V.
    Via GlobeNewswire
    News headline image
    NewAmsterdam Pharma Announces Upcoming Presentations at the Alzheimer's Association International Conference (AAIC) 2026
    From NewAmsterdam Pharma N.V.
    Via GlobeNewswire
    News headline image
    NewAmsterdam Pharma Announces Upcoming Presentations at the National Lipid Association (NLA) 2026 Scientific Sessions
    From NewAmsterdam Pharma N.V.
    Via GlobeNewswire
    News headline image
    NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in June
    From NewAmsterdam Pharma N.V.
    Via GlobeNewswire
    News headline image
    NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in May
    From NewAmsterdam Pharma N.V.
    Via GlobeNewswire
    News headline image
    NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results
    From NewAmsterdam Pharma N.V.
    Via GlobeNewswire
    News headline image
    NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From NewAmsterdam Pharma N.V.
    Via GlobeNewswire
    News headline image
    NewAmsterdam Pharma Announces Three Presentations at the 2026 American College of Cardiology Annual Scientific Session
    From NewAmsterdam Pharma N.V.
    Via GlobeNewswire
    News headline image
    NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From NewAmsterdam Pharma N.V.
    Via GlobeNewswire
    News headline image
    NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in March
    From NewAmsterdam Pharma N.V.
    Via GlobeNewswire
    News headline image
    NewAmsterdam Pharma Reports Full Year 2025 Financial Results and Provides Corporate Update
    From NewAmsterdam Pharma N.V.
    Via GlobeNewswire
    News headline image
    NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From NewAmsterdam Pharma N.V.
    Via GlobeNewswire
    News headline image
    NewAmsterdam Pharma to Present at the Guggenheim Emerging Outlook: Biotech Summit
    From NewAmsterdam Pharma N.V.
    Via GlobeNewswire
    News headline image
    NewAmsterdam Pharma Highlights 2025 Achievements and Outlines 2026 Strategic Priorities
    From NewAmsterdam Pharma N.V.
    Via GlobeNewswire
    News headline image
    NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From NewAmsterdam Pharma N.V.
    Via GlobeNewswire
    News headline image
    NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From NewAmsterdam Pharma N.V.
    Via GlobeNewswire
    News headline image
    NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in December
    From NewAmsterdam Pharma N.V.
    Via GlobeNewswire
    News headline image
    NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From NewAmsterdam Pharma N.V.
    Via GlobeNewswire

    Frequently Asked Questions

    Is NewAmsterdam Pharma Company N.V. - Warrant publicly traded?
    Yes, NewAmsterdam Pharma Company N.V. - Warrant is publicly traded.
    What exchange does NewAmsterdam Pharma Company N.V. - Warrant trade on?
    NewAmsterdam Pharma Company N.V. - Warrant trades on the Nasdaq Stock Market
    What is the ticker symbol for NewAmsterdam Pharma Company N.V. - Warrant?
    The ticker symbol for NewAmsterdam Pharma Company N.V. - Warrant is NAMSW on the Nasdaq Stock Market
    What is the current price of NewAmsterdam Pharma Company N.V. - Warrant?
    The current price of NewAmsterdam Pharma Company N.V. - Warrant is 14.44
    When was NewAmsterdam Pharma Company N.V. - Warrant last traded?
    The last trade of NewAmsterdam Pharma Company N.V. - Warrant was at 09/03/26 01:21 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.